Ildong Holdings Co., Ltd. (KRX:000230)
South Korea
· Delayed Price · Currency is KRW 10,150
-650 (-6.02%)
Mar 9, 2026, 3:30 PM KST
Ildong Holdings Revenue
Ildong Holdings had revenue of 150.51B KRW in the quarter ending September 30, 2025, a decrease of -6.37%. This brings the company's revenue in the last twelve months to 620.44B, down -1.95% year-over-year. In the year 2024, Ildong Holdings had annual revenue of 657.57B with 2.99% growth.
Revenue (ttm)
620.44B
Revenue Growth
-1.95%
P/S Ratio
0.18
Revenue / Employee
8.62B
Employees
72
Market Cap
114.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 657.57B | 19.12B | 2.99% |
| Dec 31, 2023 | 638.45B | -37.09B | -5.49% |
| Dec 31, 2022 | 675.54B | 83.17B | 14.04% |
| Dec 31, 2021 | 592.37B | -4.09B | -0.69% |
| Dec 31, 2020 | 596.47B | 304.25B | 104.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kyongbo Pharmaceutical | 252.20B |
| Jeil Pharma Holdings | 707.15B |
| CKD Bio | 159.93B |
| HANDOK | 516.37B |
| Kukje Pharma | 173.80B |
| Whan In Pharm | 256.32B |
| Ilsung Is | 66.51B |
| Dongwha Pharm.Co.,Ltd | 493.33B |